PDS Biotechnology Corporation Signs Worldwide Licensing Agreement With Merck KGaA (MKGAF.PK) for Versamune™
7/9/2012 7:35:43 AM
More...
|
PDS Biotechnology Corporation Awarded $1.28M National Cancer Institute Contract
3/2/2010 8:53:57 AM
More...
|
PDS Biotechnology Corporation Demonstrates Pre-Clinical Safety of its Versamune(TM)-Based HPV Product
10/6/2009 8:54:32 AM
More...
|
PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG
2/24/2009 11:00:18 AM
More...
|
PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
11/7/2008 7:41:08 AM
More...
|